Pubblicazioni

Definitive weekly hypofractionated radiotherapy in surgery-ineligible older adults with cutaneous squamous cell carcinoma of the head and neck region

2024 - JOURNAL OF GERIATRIC ONCOLOGY

De Felice, Francesca; Serpone, Maria; Cattaneo, Carlo Guglielmo; Di Giammarco, Federico; Fallico, Alberto; Delle Donne, Alessia; Lanzilao, Maura; Vitti, Elisa; Marampon, Francesco; Musio, Daniela; Tombolini, Vincenzo; Minniti, Giuseppe

De Felice scheme: No risk at all of brain radionecrosis?âAuthors' reply

2024 - HEAD & NECK

Efficacy of Cemiplimab in a Patient Affected by Cutaneous Squamous Cell Carcinoma and Myelodysplastic Syndrome

2023 - DERMATOLOGY PRACTICAL & CONCEPTUAL

Proietti, Ilaria; Tolino, Ersilia; Bernardini, Nicoletta; Di Fraia, Marco; Skroza, Nevena; Potenza, Concetta

Surgeryâineligible elderly patients with cutaneous squamous cell carcinoma of the head and neck region gain clinical benefit from definitive weekly hypofractionated radiotherapy

2023 - HEAD & NECK

Weekly hypofractionated radiation therapy in elderly non-resectable cutaneous squamous cell carcinoma of the head and neck region

2021 - LA RADIOLOGIA MEDICA

De Felice, F.; Musio, D.; Tombolini, V.

Real world data of cemiplimab in locally advanced and metastatic cutaneous squamous cell carcinoma

2021 - EUROPEAN JOURNAL OF CANCER

Baggi, A.; Quaglino, P.; Rubatto, M.; Depenni, R.; Guida, M.; Ascierto, P. A.; Trojaniello, C.; Queirolo, P.; Saponara, M.; Peris, K.; Spagnolo, F.; Bianchi, L.; De Galitiis, F.; Potenza, M. C.; Proietti, I.; Marconcini, R.; Botticelli, A.; Barbieri, V.; Licitra, L.; Alfieri, S.; Ficorella, C.; Cortellini, A.; Fargnoli, C.; Troiani, T.; Tondulli, L.; Bossi, P.

Management of myelofibrosis and concomitant advanced cutaneous squamous cell carcinoma with ruxolitinib associated with cemiplimab

2021 - ANNALS OF HEMATOLOGY

DI PRIMA, Alessio; Botticelli, Andrea; Scalzulli, Emilia; Colafigli, Gioia; Pepe, Sara; Lisi, Chiara; Marchetti, Paolo; Martelli, Maurizio; FoÃ , Robin; Breccia, Massimo

Case report: Cetuximab use in advanced cutaneous squamous cell carcinoma resistant to chemotherapy [version 1; peer review: 1 approved with reservations]

2019 - F1000RESEARCH

Sernicola, A.; Lampitelli, S.; Grassi, S.; Richetta, A. G.; Calvieri, S.